Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CCCCCCCC
Showing 7 of 22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in C4 THERAPEUTICS INC

CITADEL ADVISORS LLC holds 4.2M shares of CCCC (C4 THERAPEUTICS INC), worth $19.6M as of 2026-Q2. The position was increased (+66.8% shares). CCCC represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$19.6M

Current Shares

4.2M

Total Value Change

+$19.4M

Total Shares Change

+4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.2M
+66.8%
$19.6M0.0%$4.67
42
2026-Q1
Increased
2.5M
+460.7%
$6.6M0.0%$2.95
44
2025-Q4
Decreased
447,808
-7.0%
$855,3130.0%$1.96
0
2025-Q3
New
481,449
-
$1.1M0.0%$2.23
35
2025-Q1
Exited
0
-100.0%
$00.0%$1.75
0
2024-Q4
Decreased
28,616
-16.1%
$103,0180.0%$3.64
0
2024-Q3
Decreased
34,097
-90.9%
$194,3530.0%$5.89
0

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used